


Pathelium Revenue
Biotechnology Research • Miami, Florida, United States • 1-10 Employees
Pathelium revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at Pathelium
Ndubi Amos
Founder & CEO
Company overview
| Headquarters | Miami, Florida, United States |
| Website | |
| NAICS | 541714 |
| Keywords | Precision Medicine, Regenerative Medicine, Chronic Diseases, Gene Editing, Crispr Gene Editing, Ai-Driven Biomaterials, Corneal Regeneration, Ecm Scaffolding, Epithelial Stem Cell Technology |
| Founded | 2025 |
| Employees | 1-10 |
| Socials |
About Pathelium
Pathelium is a pioneering biotech startup focused on unlocking the regenerative potential of epithelial tissues to treat and cure chronic diseases. Our science is built on the insight that over 70% of chronic diseases (such as IBP,COPD, and fibrosis) begin with epithelial dysfunction—the body's first line of defense across the skin, lungs, and intestines. Where big pharmas treat symptoms, generic stem cells lack precision, and tissue engineers miss function, we are pioneering in rebuilding the body's critical barrier to cure disease, not manage it.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Pathelium has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Pathelium has never raised funding before.
Frequently asked questions
4.8
40,000 users



